Table 1.
Characteristics of Convalescent Coronavirus Disease 2019 Patients and BNT162b2 Vaccinees
| COVID-19 Severity | |||||||
|---|---|---|---|---|---|---|---|
| No. of Patients | Mean Age, y (Range) | Sex, Male/Female | Mean Weeks Since Diagnosis (Range) | Outpatient | Hospitalized | ICU | Figure |
| Convalescent COVID-19 patients | |||||||
| 37 | 41 (19–74) | 13/24 | 9.03 (3–38) | 33 | 1 | 3 | Figure 1 |
| 26 | 37 (19–57) | 10/16 | 8.5 (3–36) | 25 | 1 | 0 | Figure 3A Supplementary Figure 3 |
| 20 | 54 (20–84)a | 12/8 | 10.1 (7–14) | 4 | 9 | 7 | Figure 4A |
| BNT162b2 vaccinees | |||||||
| 148 | 40.6 (22–66) | 63/85 | NA | NA | NA | NA | … |
Abbreviations: COVID-19, coronavirus disease 2019; ICU, intensive care unit; NA, not applicable.
aP < .001, analysis of variance (with Bonferroni post hoc analysis) compared to the other convalescent COVID-19 patients and the vaccinees. No significant differences for age or sex between the groups.